Essential Use Nominations

• Handbook on Essential Use Nominations - 2009

• Handbook on Essential Use Nominations (2005)

• Downloadable Forms:

  • Recommended Form for Nomination for Essential Use (Other than MDIs)
  • Recommended Form for Nomination of the Aerosol Metered-Dose Inhaler (MDI) as an Essential Use
  • Reporting Accounting Framework for Essential Uses Other than Laboratory and Analytical Applications

• Plans of action regarding the phase-out of the domestic use of CFC-containing metered-dose inhalers (Decision XV/5(4)):

  • Canada
  • European Union
  • Russian Federation (E) (R)
  • United States of America

• Information on inhaler treatments for asthma and COPD that contain CFCs or that do not contain CFCs (Decisions XIV/5)

  Argentina	Eritrea	Malaysia	South Africa
  Australia	European Union	Mauritius	United States of America
  Belize	Georgia	Moldova	Uruguay
  Bosnia and Herzegovina	Guyana	Namibia
  Brazil	Hungary	New Zealand
  Bulgaria	India	Norway
  Canada	Indonesia	Oman
  China	Israel	Poland
  Croatia	Jamaica	Romania
  Cuba	Japan	Singapore
  Czech Republic	Lithuania	Slovenia
  Costa Rica	Macedonia, FYR	Sri Lanka

  
   

• Measures by Parties to facilitate the transition to chlorofluorocarbon-free metered-dose inhalers (Decision XII/2(3))

  • European Union

• Halons Management Strategies Reported by the Parties (Decision X/7(2))

• Transition Strategy to Non-CFC Metered Dose Asthma Inhalers (MDIs) (Decision IX/19(5))

  • Canada, (F)
  • Czech Republic
  • European Union, (F), (S)
  • Hungary
  • New Zealand
  • Poland
  • United States of America

• Summary of Essential Use Exemptions approved by the Meeting of the Parties (up to the 20th Meeting)